Home › Epstein-Barr Virus Infections › Maryland
Epstein-Barr Virus Infections clinical trials in Maryland
6 studies for Epstein-Barr Virus Infections are looking for participants at sites in Maryland.
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT03258567Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 29 · All sexes · Updated Sep 8, 2026 · NCT06908096Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Aug 25, 2026 · NCT05389423A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- National Institutes of Health, Bethesda
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT05592626Genetic Studies of Chronic Active Epstein-Barr Disease
- National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 1 to 120 · All sexes · Updated Jul 28, 2026 · NCT00032513EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
- Johns Hopkins, Baltimore
RecruitingPhase 2
1 Month – 79 Years · All sexes · Updated Aug 8, 2025 · NCT03266653From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.